| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $148K | -50.2% | -43.3% |
| Cost of Revenue | $140K | +28.4% | +32.1% |
| Gross Profit | $8K | -95.7% | -94.8% |
| R&D Expense | $1.8M | -5.8% | -24.8% |
| SG&A Expense | $2.1M | +16.7% | +1.9% |
| Operating Income | -$3.9M | -10.3% | +9.7% |
| Pre-tax Income | -$3.9M | -212.2% | +2.0% |
| Income Tax | $0 | — | — |
| Net Income | -$3.9M | -13.3% | +2.0% |
| EPS (Basic) | -$2.34 | -13.0% | +4.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $7.0M | -37.7% | -67.3% |
| Accounts Receivable | $133K | -62.4% | -60.9% |
| Current Assets | $14.3M | -21.1% | -49.1% |
| Total Assets | $19.7M | -15.2% | -36.5% |
| Current Liabilities | $1.9M | +2.1% | -27.6% |
| Total Liabilities | $4.2M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.5M | -90.0% | — |
| Capital Expenditures | $859K | +91.7% | — |
| Investing Cash Flow | $7.5M | +114.0% | — |
| Financing Cash Flow | -$54K | -50.0% | — |
| Free Cash Flow | -$8.3M | -90.2% | — |
| +43.7% |
| Stockholders' Equity | $15.5M | -18.7% | -44.8% |